Voyager Therapeutics

Voyager Therapeutics is advancing delivery modalities for gene therapies. Many gene therapies are in development, yet delivery of the therapy is still a major limitation. AAVs are a popular choice but require high doses and have off-target effects. Voyager is using its TRACER screening platform to enhance AAV capsids’ specificity and ability to target desired cells and tissues. Voyager’s AAVs also pass the blood-brain barrier, offering the potential to cure neurological diseases. Initial non-human primate data demonstrate the selectivity of TRACER-derived capsids to target the CNS and cardiac muscle. These capsids may enable single-dose treatment for a broad spectrum of diseases.

Jobs:

Head of Data Science

Cambridge, MA|18 days ago

Apply

General Counsel

Lexington, MA|23 days ago

Apply

IT Service Desk Analyst

Lexington, MA|25 days ago

Apply

Vice President, Genome Engineering

Cambridge, MA|44 days ago

Apply

Scientist, Histology

Cambridge, MA|45 days ago

Apply

Research Associate, Biology

Cambridge, MA|45 days ago

Apply

Scientist I, Neuroscience

Cambridge, MA|45 days ago

Apply

Research Associate/Senior Research Associate

Cambridge, MA|56 days ago

Apply

Scientist/Sr.Scientist, Translational Research

Cambridge, MA|56 days ago

Apply

IT Director of Research & Development, Clinical and Data Ana...

Lexington, MA|66 days ago

Apply

Scientist I/II,( AAV Capsid Engineering/R&D)

Cambridge, MA|98 days ago

Apply

Senior Research Associate, Translational Research

Cambridge, MA|100+ days ago

Apply